Markedsdata leveret af TwelveData og Morningstar
Genomed SA is a Polish biotechnology company focused on DNA and RNA sequencing, genetic analysis, DNA synthesis, and molecular diagnostics. Genomed SA provides services for research centers, universities, biotechnological companies, clinics, laboratories, and individual clients, supporting both scientific work and medical testing. Its core offering includes sequencing-based diagnostics for inherited and genetic diseases, with applications in areas such as prenatal testing, oncology predisposition, infertility, cystic fibrosis, neurological disorders, and other clinically relevant conditions. The company uses next-generation sequencing technologies to process genetic information and develop modern diagnostic solutions for personalized medicine. Headquartered in Warsaw, Genomed SA operates in the healthcare and life sciences market, where it serves as a specialized provider linking advanced genomics with practical laboratory and medical services.